Unraveling the tapestry of adverse cutaneous drug reactions: A clinico-epidemiological study


Original Article

Author Details : Arisha Salam, Abhinesh N*, Rekha GP, Tejaswi Challa

Volume : 10, Issue : 2, Year : 2024

Article Page : 176-181

https://doi.org/10.18231/j.ijced.2024.032



Suggest article by email

Get Permission

Abstract

Background: It is widely acknowledged that adverse drug responses on the skin can cause serious complications. Up to 2% of all adverse cutaneous medication eruptions are severe and life-threatening, however the majority of these reactions are benign. In order to quickly diagnose these grave cutaneous eruptions and start the necessary treatment, physicians should be aware of certain warning signs. To understand the causative drug, meticulous history and complete clinical examination is the key
Objective: Primary objective is to find the common group of drugs causing adverse cutaneous drug reactions. Secondary objectives are to study their morphology, gender and age distribution.
Materials and Methods: The cross-sectional study involved 130 patients. Informations including relevant history, clinical examination details, and drugs taken were noted in the pretested proforma. Quantitative and qualitative data were collected and graphically analysed. Data was studied under various aspects which included causative drugs, clinical presentation, age and gender ratio. SPSS Version 21.0 was used for most analysis and Microsoft Excel 2010 for graphical representation.
Results: Maculopapular rash, acneiform eruptions, urticarial rash, exfoliative dermatitis and fixed drug eruptions were the commonest forms of clinical presentations seen in our study. The cutaneous drug reactions were classified as per the study of Agarwal et al.
Conclusion: The limitations of treating adverse cutaneous drug reactions are the varied range of clinical symptoms, the complexity of the various drug-host interactions, and the relative scarcity of laboratory tests that are available for any conclusive and confirmatory drug-specific testing. That's why knowledge of clinical presentations and common drugs causing it is a must.
 

Keywords: Adverse cutaneous drug reactions, Drug rash with eosinophilia and systemic symptoms, Fixed drug eruptions


How to cite : Salam A, Abhinesh N, Rekha Gp, Challa T, Unraveling the tapestry of adverse cutaneous drug reactions: A clinico-epidemiological study. IP Indian J Clin Exp Dermatol 2024;10(2):176-181


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 17-01-2024

Accepted : 18-03-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2024.032


Article Metrics






Article Access statistics

Viewed: 575

PDF Downloaded: 297